Oriental Spring Venture Ltd is 10% Owner at Terns Pharmaceuticals, Inc. (TERN). They have made 1 open-market trade across 1 company since 2022, most recently 2022-11-23.
CIK 0001844154
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TERN | 529,762 | $28.1M |
Shares reported on the most recent Form 4, priced at the 2022-11-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | SELL | 2022-11-23 | 2022-11-28 | $5.50 | $8.3M | -11.4% | +43.5% | +64.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.